Abstract
Resistance to multiple drugs is a serious limitation to chemotherapy treatment of human cancers. In addition, many clinically useful drugs show limited uptake in the intestine and cannot gain access to the brain. Three multidrug efflux pumps of the ABC superfamily (P-glycoprotein/ABCB1, MRP1/ABCC1, and BCRP/ABGG2) are responsible for most drug transport out of mammalian cells. P-glycoprotein is the best characterized of the ABC drug transporters. However, the lipophilic nature of its substrates has made it difficult to directly quantitate drug binding to the protein by classical biochemical methods, and the measurement of drug transport rates has also proved challenging. In recent years, fluorescence spectroscopic approaches have proved very useful in overcoming these problems. This chapter focuses on the use of fluorescence tools to quantitate the affinity of binding of various drugs to purified P-glycoprotein and to measure its drug transport activity in reconstituted proteoliposomes in real time. The ability of various drugs to inhibit P-glycoprotein mediated transport can also be assessed using this approach.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dassa, E. and Schneider, E. (2001) The rise of a protein family: ATP-binding cassette systems. Res. Microbiol. 152, 203.
Davidson, A.L., Dassa, E., Orelle, C., and Chen, J. (2008) Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol. Mol Biol. Rev. 72, 317–364.
Dean, M., Rzhetsky, A., and Allikmets, R. (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156–1166.
Sharom, F.J. (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9, 105–127.
Deeley, R.G., Westlake, C., and Cole, S.P. (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 86, 849–899.
Calcagno, A.M., Kim, I.W., Wu, C.P., Shukla, S., and Ambudkar, S.V. (2007) ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions. Curr. Drug Deliv. 4, 324–333.
Litman, T., Druley, T.E., Stein, W.D., and Bates, S.E. (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58, 931–959.
Alvarez, M., Paull, K., Monks, A., Hose, C., Lee, J.S., Weinstein, J., Grever, M., Bates, S., and Fojo, T. (1995) Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J. Clin. Invest. 95, 2205–2214.
Sharom, F.J. 2007. Multidrug resistance protein: P-glycoprotein. In Drug Transporters: Molecular Characterization and Role in Drug Disposition (G. You and M.E. Morris, eds.). John Wiley & Sons, Hoboken, NJ, pp. 223–262.
Gottesman, M.M. (1993) How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 53, 747–754.
Holland, I.B., and Blight, M.A. (1999) ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293, 381–399.
Qu, Q., and Sharom, F.J. (2002) Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet. Biochemistry 41, 4744–4752.
Lugo, M.R. and Sharom, F.J. (2005) Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site. Biochemistry 44, 643–655.
Sharom, F.J., Yu, X., and Doige, C.A. (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein.J. Biol. Chem. 268, 24197–24202.
Lu, P., Liu, R., and Sharom, F.J. (2001) Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state. Eur. J. Biochem. 268, 1687–1697.
Sharom, F.J., Yu, X., DiDiodato, G., and Chu, J.W.K. (1996) Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem. J. 320, 421–428.
Lakowicz, J.R. (2006) Principles of Fluorescence Spectroscopy. Springer Science+Business Media, New York.
Sharom, F.J., Liu, R., Qu, Q., and Romsicki, Y. (2001) Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools. Seminars Cell Dev. Biol. 12, 257–266.
Sharom, F.J., Liu, R., Romsicki, Y., and Lu, P. (1999) Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim. Biophys. Acta 1461, 327–345.
Sharom, F.J. (2006) Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1). Biochem. Cell Biol. 84, 979–992.
Liu, R., and Sharom, F.J. (1996) Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35, 11865–11873.
Liu, R., Siemiarczuk, A., and Sharom, F.J. (2000) Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry 39, 14927–14938.
Doige, C.A., and Sharom, F.J. (1992) Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109, 161–171.
Shapiro, A.B., Corder, A.B., and Ling, V. (1997) P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. Eur. J. Biochem. 250, 115–121.
Kolaczkowski, M., van der Rest, M., Cybularz-Kolaczkowska, A., Soumillion, J.P., Konings, W.N., and Goffeau, A. (1996) Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem. 271, 31543–31548.
Shapiro, A.B., and Ling, V. (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250, 130–137.
Doige, C.A., and Sharom, F.J. (1991) Strategies for the purification of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Protein Expr. Purif. 2, 256–265.
Doige, C.A., Yu, X., and Sharom, F.J. (1992) ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109, 149–160.
Sharom, F.J., Yu, X., Chu, J.W.K., and Doige, C.A. (1995) Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem. J. 308, 381–390.
Peterson, G.L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346–356.
Qu, Q., Chu, J.W., and Sharom, F.J. (2003) Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism. Biochemistry 42, 1345–1353.
Acknowledgments
Research in the author’s laboratory on the P-glycoprotein multidrug efflux pump is supported by an operating grant from the Canadian Cancer Society.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sharom, F.J., Liu, R., Vinepal, B. (2010). Fluorescence Studies of Drug Binding and Translocation by Membrane Transporters. In: Yan, Q. (eds) Membrane Transporters in Drug Discovery and Development. Methods in Molecular Biology, vol 637. Humana Press. https://doi.org/10.1007/978-1-60761-700-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-60761-700-6_7
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-699-3
Online ISBN: 978-1-60761-700-6
eBook Packages: Springer Protocols